What is endometrial cancer?
Endometrial cancer develops in the cells that form the inner lining of the uterus, or the endometrium, and is one of the most common cancers of the female reproductive system among American women. In 2010, approximately 43,000 women in the United States were estimated to have been diagnosed and almost 8,000 to have died of endometrial cancer.1 This cancer occurs most commonly in women aged 60 years or older. About 69 percent of endometrial cancers are diagnosed at an early stage, and as a result about 83 percent of women will survive five years following the time of diagnosis. View additional information on endometrial cancer.
What types of discoveries about uterine corpus endometrial carcinoma do The Cancer Genome Atlas (TCGA) researchers hope to make?
- Pinpoint unique genomic changes that distinguish serous endometrial tumors from endometrioid endometrial tumors
- Identify genomic differences between early-stage and late-stage endometrioid tumors
- Isolate specific patterns of genomic changes connected to tumor recurrence, either within or between endometrial tumor subtypes
Where can I find more information about the TCGA Research Network’s studies or studies using TCGA data?
Where can I find clinical trials to treat endometrial cancer that are supported by the National Cancer Institute (NCI)?
View a list of NCI-supported endometrial cancer clinical trials that are now accepting patients.
1American Cancer Society: Cancer Facts and Figures 2010. Atlanta, GA: American Cancer Society, 2010.